These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 33526991)

  • 1. Identification novel prognostic signatures for Head and Neck Squamous Cell Carcinoma based on ceRNA network construction and immune infiltration analysis.
    Zhou H; He Y; Li L; Wu C; Hu G
    Int J Med Sci; 2021; 18(5):1297-1311. PubMed ID: 33526991
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of Novel Biomarkers for Predicting Prognosis and Immunotherapy Response in Head and Neck Squamous Cell Carcinoma Based on ceRNA Network and Immune Infiltration Analysis.
    Guo Y; Pan WK; Wang ZW; Su WH; Xu K; Jia H; Chen J
    Biomed Res Int; 2021; 2021():4532438. PubMed ID: 34917682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
    Yang L; Lu P; Yang X; Li K; Chen X; Qu S
    Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
    Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
    Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
    [No Abstract]   [Full Text] [Related]  

  • 5. Development and validation of a novel ferroptosis-related gene signature for predicting prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    He F; Chen Z; Deng W; Zhan T; Huang X; Zheng Y; Yang H
    Int Immunopharmacol; 2021 Sep; 98():107789. PubMed ID: 34130150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment and validation of immune microenvironmental gene signatures for predicting prognosis in patients with head and neck squamous cell carcinoma.
    Wang J; Tian Y; Zhu G; Li Z; Wu Z; Wei G; Zhuang L; Li Z; Chen X; Zhang X; Zheng J; Cai G
    Int Immunopharmacol; 2021 Aug; 97():107817. PubMed ID: 34091115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune Infiltration-Related ceRNA Network Revealing Potential Biomarkers for Prognosis of Head and Neck Squamous Cell Carcinoma.
    Zhao S; Peng M; Wang Z; Cao J; Zhang X; Yu R; Huang T; Lian W
    Dis Markers; 2022; 2022():1014347. PubMed ID: 36097539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seven Immune-Related Genes' Prognostic Value and Correlation with Treatment Outcome in Head and Neck Squamous Cell Carcinoma.
    Mu R; Shen Y; Guo C; Zhang X; Yang H; Yang H
    Mediators Inflamm; 2023; 2023():8533476. PubMed ID: 39282247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma.
    Zhong Z; Hong M; Chen X; Xi Y; Xu Y; Kong D; Deng J; Li Y; Hu R; Sun C; Liang J
    BMC Med Genomics; 2020 Mar; 13(1):57. PubMed ID: 32228580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel comprehensive immune-related gene signature as a promising survival predictor for the patients with head and neck squamous cell carcinoma.
    Fang R; Iqbal M; Chen L; Liao J; Luo J; Wei F; Wen W; Sun W
    Aging (Albany NY); 2021 Apr; 13(8):11507-11527. PubMed ID: 33867351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated analysis of lncRNA-associated ceRNA network in p16-positive and p16-negative head and neck squamous cell carcinoma.
    Yang Y; Feng L; Wang R; Ma H; He S; Fang J
    Medicine (Baltimore); 2022 Aug; 101(33):e26120. PubMed ID: 35984201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Immune-Related Prognostic Biomarkers Associated with HPV-Positive Head and Neck Squamous Cell Carcinoma.
    Chen Y; Nie J; Li X; Fan T; Deng X; Liang D; Song G
    J Immunol Res; 2021; 2021():6661625. PubMed ID: 33506058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a novel ceRNA network related to prognosis and immunity in HNSCC based on integrated bioinformatic investigation.
    Liu H; Hei G; Zhang L; Jiang Y; Lu H
    Sci Rep; 2022 Oct; 12(1):17560. PubMed ID: 36266384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    Zhu W; Ye Z; Chen L; Liang H; Cai Q
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of competitive endogenous RNAs network associated with head and neck squamous cell carcinoma.
    Fang XN; Yin M; Li H; Liang C; Xu C; Yang GW; Zhang HX
    Sci Rep; 2018 Jul; 8(1):10544. PubMed ID: 30002503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitination-Related Gene Signature, Nomogram and Immune Features for Prognostic Prediction in Patients with Head and Neck Squamous Cell Carcinoma.
    Yang H; Zhou L; Shi M; Yu J; Xie Y; Sun Y
    Genes (Basel); 2024 Jul; 15(7):. PubMed ID: 39062659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The exploration of new therapeutic targets for HPV-negative head and neck squamous cell cancer through the construction of a ceRNA network and immune microenvironment analysis.
    Wang Z; Liu T; Li G; Cao Z
    J Cell Biochem; 2020 Jun; 121(5-6):3426-3437. PubMed ID: 31898341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a nomogram based on an 8-lncRNA signature as a novel diagnostic biomarker for head and neck squamous cell carcinoma.
    Mao R; Chen Y; Xiong L; Liu Y; Zhang T
    Aging (Albany NY); 2020 Oct; 12(20):20778-20800. PubMed ID: 33091878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune-related miRNA signature identifies prognosis and immune landscape in head and neck squamous cell carcinomas.
    Ma B; Li H; Qiao J; Meng T; Yu R
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33111959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ceRNA network development and tumor-infiltrating immune cell analysis in hepatocellular carcinoma.
    Chen L; Zou W; Zhang L; Shi H; Li Z; Ni C
    Med Oncol; 2021 Jun; 38(7):85. PubMed ID: 34148185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.